#United States #Boulder #Verb Biotics #LP815 Probiotic #Treat Therapeutics

Recent Findings on LP815® Probiotic

A significant new study has confirmed that Lactiplantibacillus plantarum LP815 can effectively mitigate anxiety and aggression in dogs, promoting a healthier lifestyle for our canine companions. Conducted by Treat Therapeutics, this innovative research emphasizes the probiotic's promise, particularly focusing on its role in enhancing the well-being of pets across various homes.

The Study at a Glance

This interventional study involved 40 dogs exhibiting behavioral issues. These dogs were monitored in their usual environments over a four-week period, with the results showcasing impressive outcomes. Utilizing both owner surveys and wearable activity trackers, the research team was able to make informed assessments of the dogs' behavioral improvements.

Key Findings:

• - Aggression Reduction: Dogs receiving the LP815 probiotic demonstrated notable decreases in aggression, marked by a significant p-value of 0.0047. This indicates a robust response to the treatment, offering hope to pet owners struggling with aggressive behaviors in their dogs.
• - Lowered Anxiety Levels: The study found that the probiotic also led to a significant reduction in anxiety manifestations, as evidenced by lower p-values (0.0010) associated with excessive vocalization and pacing. These improvements point towards a calmer demeanor in pets, essential for their overall mental health.
• - Enhanced Sleep Quality: The LP815 probiotic played a crucial role in improving sleep quality among study participants. Results indicated more consistent sleep patterns, a reduction in daytime naps, and earlier wake times, which implies deeper, more restful sleep with no reported drowsiness the following day.
• - Safety Profile: One of the most reassuring aspects of this study was the absence of side effects. No notable gastrointestinal disturbances or adverse events were reported, ensuring that LP815 is a safe option for canine companions.

Expert Opinions

Dr. Noah Zimmerman, Chief Scientific Officer at Verb Biotics, emphasizes that LP815 addresses the core issues of stress and behavioral challenges through microbiome modulation rather than simply masking symptoms. Emmanuel Bijaoui, CEO of Treat Therapeutics, articulates the novelty of this endeavor, noting that LP815 is among the first probiotics to offer peer-reviewed evidence of behavioral benefits under real-world conditions.

This research not only establishes LP815's validity as a safe and effective choice for canine anxiety and aggression but also sets a new benchmark for pet wellness interventions. The findings will likely encourage pet supplement brands to incorporate such scientifically backed products into their offerings.

Looking Ahead

These promising results position LP815 as a potential game-changer for the wellness of companion animals. As the understanding of the gut-brain connection progresses, this probiotic provides a solid basis for pet owners seeking natural solutions to behavioral issues. With rigorous scientific support behind its efficacy, LP815 could herald a new era in fostering calm and balanced canine behavior.

For more detailed reading, the full study is published in the journal Animals. Interested readers can access it here.

About Verb Biotics

Verb Biotics stands out as a B2B biotech firm dedicated to advancing microbiome technology. By delivering clinically validated ingredients tailored for diverse applications—from pet care to functional foods—the company leverages sophisticated biology and machine-learning techniques to drive measurable health outcomes.

In summary, the findings surrounding LP815 could revolutionize how we approach canine anxiety and aggression, offering a scientifically validated, safe, and effective solution for dogs in need.